Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1607 of 5804
-
New hope for kids with severe psoriasis: drug trial shows promise
Disease control OngoingThe study has been designed with three components. Part A is an open label PK study followed by a randomized trial component (Part B) followed by open label Long Term Extension (LTE). The initial PK analysis is first done in adolescent subjects (12 to \<18 years) before initiati…
Phase: PHASE2, PHASE3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New yellow fever vaccine shows promise in early trial
⭐️ VACCINE ⭐️ CompletedThe primary objectives of the study are: * To describe the safety profile of each of the 3 dosages of vYF and of YF-VAX® within the 28 days post-vaccination and up to the 6 months (Day 180) post-vaccination visit * To describe the antibody responses elicited by each of the 3 dos…
Phase: PHASE1 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:51 UTC
-
Can IV iron prevent anemia in pregnant women?
Prevention CompletedPrevalence of anemia in Asia is more than 50%. All woman who book for antenatal care with non-anaemic iron deficiency (NAID) can be offered therapeutic doses of parentral iron, as a directly observed complete therapy, to prevent of maternal anaemia and fetal growth restriction. T…
Phase: PHASE4 • Sponsor: Services Institute of Medical Sciences, Pakistan • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Bone-Delivered antibiotics could spare joint infection patients from repeat surgeries
Disease control ENROLLING_BY_INVITATIONPurpose of Study: In order to improve upon the variable results seen in irrigation and debridement for periprosthetic infection, we ask if the use of intraosseous regional administration of antibiotics at the time of irrigation and debridement will improve the modest success of s…
Phase: PHASE4 • Sponsor: OrthoCarolina Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New study aims to uncover cancer genes in underrepresented populations
Knowledge-focused Recruiting nowThis clinical trial examines the integration of cancer genetic testing in various ethnic populations. Studying individuals and families at risk of cancer may help identify cancer genes and other persons at risk. The information from this study may provide an opportunity for cance…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Blood test may guide lung cancer therapy, avoiding unnecessary chemo
Disease control OngoingThis research study is studying to see if a blood test, collected at different times during the treatment of metastatic non-small lung cancer, can be used to detect early response in patients being treated with pembrolizumab and use that information to determine whether patients …
Phase: PHASE2 • Sponsor: Julia K. Rotow, MD • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New daily pill aims to keep ulcerative colitis in check
Disease control CompletedA phase 2b study to evaluate the long-term efficacy and safety study of ABX464 50mg as maintenance therapy in patients with moderate to severe Ulcerative Colitis.
Phase: PHASE2 • Sponsor: Abivax S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for Chemo-Resistant lung cancers?
Disease control CompletedThe purpose of this study is to: * Test how well the study medicine Abemaciclib, a CDK4/6 inhibitor, works to shrink lung cancer tumors in the body. * Test the safety of Abemaciclib when given to participants with small cell lung cancer (SCLC), large cell neuroendocrine lung can…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can chemotherapy reboot immunotherapy in resistant melanoma?
Disease control CompletedPROMIT is a single arm phase 2 trial evaluating the clinical activity of immune checkpoint blockade (ICB) after administration of dacarbazine (DTIC) in patients with unresectable or metastatic, BRAF wildtype melanoma with primary resistance to anti-programmed-cell-death-1 (PD-1/P…
Phase: PHASE2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Simple stretches and massages may stop chronic pain after breast cancer surgery
Prevention CompletedMyofascial pain syndrome is a common cause of chronic pain characterized by myofascial pain and trigger points. Recommendations regarding management of pain after breast cancer don't mention myofascial syndrome despite a study suggests possible myofascial syndrome with roughly 75…
Phase: NA • Sponsor: Center Eugene Marquis • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
New PET scan could outshine MRI for prostate cancer detection
Diagnosis Recruiting now68Ga-PSMA-11 is a widely used radiotracer targeting PSMA. In this study, we investigated the diagnostic efficacy of 68Ga-PSMA-11 PET imaging (PET/CT or PET/MRI) in patients with newly diagnosed, treatment-naive prostate cancer, and performed a head-to-head comparison with multi-p…
Phase: PHASE2, PHASE3 • Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Could a common diabetes drug help fight ALS?
Disease control OngoingThe primary objective is to assess the safety and tolerability of Metformin in subjects with C9orf72 amyotrophic lateral sclerosis administered for 24 weeks. The overall objective is to determine if Metformin is safe in C9orf72 ALS patients and is a potentially viable therapeutic…
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New MS drug trial targets kids: could ocrelizumab slow relapses?
Disease control OngoingThis 2-year study will evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamic (PD) effects of ocrelizumab in children and adolescents ages ≥ 10 to ≤ 18 years with relapsing-remitting multiple sclerosis (RRMS). The data from this study will serve to determine the…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Laser and radiation combo takes on recurrent brain tumors
Disease control Recruiting nowThe purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with recurrent gliomas.
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Exercise may ease fatigue in advanced breast cancer patients
Symptom relief OngoingCurrently, the effect of exercise on metastatic breast cancer has not been extensively studied, even though the benefits are evident in the curative setting. The investigators designed the EFFECT study to assess the effects of a 9-month structured and individualised exercise inte…
Phase: NA • Sponsor: UMC Utrecht • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New trial aims to cut side effects of radiation for recurrent prostate cancer
Disease control OngoingThis phase II trial studies the side effects of radiation therapy \[hypofractionated proton beam radiation therapy (PBRT) or intensity-modulated radiation therapy (IMRT)\] for the treatment of prostate cancer that has come back (recurrent) or that has spread to a limited number o…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Hope for frail lung cancer patients: immunotherapy combo shows promise
Disease control CompletedSmall cell lung cancer (SCLC) is a rapidly proliferating, neuroendocrine tumor that accounts for about 15% of all lung cancers. Most patients have metastases at primary diagnosis involving sites like bone, adrenal glands, liver and brain. Compared with non-small-cell lung cancer…
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 26, 2026 15:06 UTC
-
Could an immune booster improve rectal cancer treatment?
Disease control Recruiting nowThe purpose of this research study is to evaluate epacadostat when given with routine radiation therapy and chemotherapy (capecitabine and oxaliplatin) to treat rectal cancer before routine surgery is performed to remove the tumor.
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Common antibiotic could shield hearts after attack
Disease control CompletedCurrent medical treatment allows more people to survive heart attacks than in the past. However, some of the survivors suffer heart disease and require hospitalization later on. The causes behind this heart disease (heart failure) after a heart attack are poorly understood. Matr…
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could a common ED drug shield prostate cancer patients from chemo nerve pain?
Prevention CompletedDocetaxel is a standard chemotherapy for metastatic prostate cancer but is associated with dose-limiting peripheral neuropathy. Currently, no pharmacologic agents are established for prevention. Tadalafil, a PDE5 inhibitor, may improve microvascular perfusion and offer neuroprote…
Phase: PHASE2 • Sponsor: Tri-Service General Hospital • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC